Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial ...

Nov 22 (Reuters) - A trial ended with a hung jury on Thursday in a California man's lawsuit alleging Boehringer Ingelheim's discontinued heartburn drug Zantac gave him bladder cancer. The jury in ...

GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion. By Rebecca Robbins The British drug maker GSK said on Wednesday that it ...

GlaxoSmithKline agreed on Sept. 17 to settle out of the first Zantac trial in California, which began this month in Oakland. GSK won two defense verdicts in Illinois earlier this year but faced 75,000 ...

Delaware—the first of the 13 colonies to ratify the U.S. Constitution—also prides itself on being the state of incorporation for "more than 66% of the Fortune 500." The Delaware Supreme Court recently ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar ...

In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez ...

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The lawsuits ...

An Illinois woman’s lawsuit claiming she developed colorectal cancer from taking the heartburn drug Zantac for nearly 20 years goes to trial this week — a first among many similar claims made ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK (GSK.L), opens new tab and other companies, causes cancer is set to begin this week in Chicago ...

Sanofi will pay $100 million—or approximately $25,000 each—to roughly 4,000 claimants who filed lawsuits saying that the French company failed to warn users that its heartburn medicine Zantac ...